XSTOXPC
Market cap1mUSD
Dec 23, Last price
0.10SEK
1D
1.00%
1Q
-8.18%
IPO
-97.44%
Name
XP Chemistries AB
Chart & Performance
Profile
XP Chemistries AB, a biotechnology company, develops and produces forest-based capsaicin and analogues. It offers animal feed ingredients, cosmetic ingredients, pure capsaicinoids, and self-defense liquid and ingredients. The company was incorporated in 2018 and is based in Sundsvall, Sweden.
Valuation
Title SEK in thousands, except ratios and share amounts | FY | FY | FY | FY | FY |
---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | |
Income | |||||
Revenues | 664 -37.14% | 1,056 277.89% | 279 651.38% | ||
Cost of revenue | 328 | 567 | 3,856 | ||
Unusual Expense (Income) | |||||
NOPBT | 336 | 489 | (3,577) | ||
NOPBT Margin | 50.57% | 46.31% | |||
Operating Taxes | (1,937) | (1,909) | (1,165) | ||
Tax Rate | |||||
NOPAT | 2,272 | 2,398 | (2,411) | ||
Net income | (8,039) 1.55% | (7,917) 74.17% | (4,545) 110.53% | ||
Dividends | |||||
Dividend yield | |||||
Proceeds from repurchase of equity | 4,040 | 5,598 | 38,551 | ||
BB yield | -108.94% | -33.03% | -81.16% | ||
Debt | |||||
Debt current | |||||
Long-term debt | |||||
Deferred revenue | |||||
Other long-term liabilities | 888 | ||||
Net debt | (7,827) | (22,459) | (29,567) | ||
Cash flow | |||||
Cash from operating activities | (9,083) | (9,853) | (4,989) | ||
CAPEX | (27) | (1,949) | (3,141) | ||
Cash from investing activities | (2,328) | (1,949) | (6,314) | ||
Cash from financing activities | 4,040 | 5,598 | 32,704 | ||
FCF | 1,612 | 1,936 | (4,617) | ||
Balance | |||||
Cash | 7,827 | 15,198 | 21,402 | ||
Long term investments | 1 | 7,261 | 8,165 | ||
Excess cash | 7,794 | 22,406 | 29,553 | ||
Stockholders' equity | (15,493) | (9,592) | (1,875) | ||
Invested Capital | 41,181 | 38,641 | 33,176 | ||
ROIC | 5.69% | 6.68% | |||
ROCE | 1.31% | 1.68% | |||
EV | |||||
Common stock shares outstanding | 31,163 | 30,931 | 15,372 | ||
Price | 0.12 -78.28% | 0.55 -82.27% | 3.09 | ||
Market cap | 3,708 -78.12% | 16,950 -64.32% | 47,500 | ||
EV | (4,119) | (5,509) | 17,933 | ||
EBITDA | 1,502 | 1,844 | (3,352) | ||
EV/EBITDA | |||||
Interest | 32 | 472 | |||
Interest/NOPBT | 6.55% |